Chronic hypertension pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
While the mechanisms underlying secondary hypertension are well understood, the mechanisms underlying primary or essential hypertension are poorly understood.
While the mechanisms underlying secondary hypertension are well understood, the mechanisms underlying primary or essential hypertension are poorly understood.  It has been postulated that polygenic influences, increased arterial collagen with aging, salt consumption and sensitivity, [[hyperinsulinemia]] as part of the [[metabolic syndrome]] and renin may all play a role.


==Time Dependence of Pathophysiology==
==Time Dependence of Pathophysiology==
Line 17: Line 17:
Genetics account for approximately 30% of the expression of the disorder.  Hypertension is heritable and [[polygenic]] (caused by more than one gene) and a few candidate [[genes]] have been identified.<ref name="polymorphism">{{cite journal |author= Sagnella GA, Swift PA |journal=Current Pharmaceutical Design |title=The Renal Epithelial Sodium Channel: Genetic Heterogeneity and Implications for the Treatment of High Blood Pressure |year = 2006 |month = June |volume = 12 |issue = 14 |pages = 2221-2234 |id = PMID 16787251}}</ref><ref name="polymorphism2">{{cite journal |author= Johnson JA, Turner ST |journal=Current Opinion in Molecular Therapy |title=Hypertension pharmacogenomics: current status and future directions. |year = 2005 |month = June |volume = 7 |issue = 3 |pages = 218-225 |id = PMID 15977418}}</ref><ref name="polymorphism3">{{cite journal|author= Hideo Izawa; Yoshiji Yamada et al |journal=Hypertension |title=Prediction of Genetic Risk for Hypertension |year = 2003 |month = May |volume = 41 |issue = 5 |pages = 1035-1040 |id = PMID 12654703 | url=http://hyper.ahajournals.org/cgi/content/short/01.HYP.0000065618.56368.24v1}}</ref>
Genetics account for approximately 30% of the expression of the disorder.  Hypertension is heritable and [[polygenic]] (caused by more than one gene) and a few candidate [[genes]] have been identified.<ref name="polymorphism">{{cite journal |author= Sagnella GA, Swift PA |journal=Current Pharmaceutical Design |title=The Renal Epithelial Sodium Channel: Genetic Heterogeneity and Implications for the Treatment of High Blood Pressure |year = 2006 |month = June |volume = 12 |issue = 14 |pages = 2221-2234 |id = PMID 16787251}}</ref><ref name="polymorphism2">{{cite journal |author= Johnson JA, Turner ST |journal=Current Opinion in Molecular Therapy |title=Hypertension pharmacogenomics: current status and future directions. |year = 2005 |month = June |volume = 7 |issue = 3 |pages = 218-225 |id = PMID 15977418}}</ref><ref name="polymorphism3">{{cite journal|author= Hideo Izawa; Yoshiji Yamada et al |journal=Hypertension |title=Prediction of Genetic Risk for Hypertension |year = 2003 |month = May |volume = 41 |issue = 5 |pages = 1035-1040 |id = PMID 12654703 | url=http://hyper.ahajournals.org/cgi/content/short/01.HYP.0000065618.56368.24v1}}</ref>


== Salt sensitivity and Diet==
== Salt Sensitivity and Diet==
[[Salt#Health effects|Sodium]] is the environmental factor that has received the greatest attention. Approximately 60% of the essential hypertension population is responsive to sodium intake. This is due to the fact that increasing amounts of salt in a person's bloodstream causes the body to draw in more water, increasing the pressure on the blood vessel walls.  In addition to sodium, choride plays an important role as it causes volume expansion thereby increasing blood pressure.  It is notable that sodium, when combined with other anions, does not increase blood pressure.  It is only when sodium is combined with chloride does the blood pressure rise. <ref>{{cite journal |author=Kurtz TW, Al-Bander HA, Morris RC |title="Salt-sensitive" essential hypertension in men. Is the sodium ion alone important? |journal=[[N. Engl. J. Med.]] |volume=317 |issue=17 |pages=1043–8 |year=1987 |month=October |pmid=3309653 |doi= |url=}}</ref>  Salt sensitivity itself is associated with increasing age, obesity, African american race, and the [[metabolic syndrome]].<ref>{{cite journal |author=Obarzanek E, Proschan MA, Vollmer WM, ''et al.'' |title=Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial |journal=[[Hypertension]] |volume=42 |issue=4 |pages=459–67 |year=2003 |month=October |pmid=12953018 |doi=10.1161/01.HYP.0000091267.39066.72 |url=http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=12953018}}</ref>
[[Salt#Health effects|Sodium]] is the environmental factor that has received the greatest attention. Approximately 60% of the essential hypertension population is responsive to sodium intake. This is due to the fact that increasing amounts of salt in a person's bloodstream causes the body to draw in more water, increasing the pressure on the blood vessel walls.  In addition to sodium, choride plays an important role as it causes volume expansion thereby increasing blood pressure.  It is notable that sodium, when combined with other anions, does not increase blood pressure.  It is only when sodium is combined with chloride does the blood pressure rise. <ref>{{cite journal |author=Kurtz TW, Al-Bander HA, Morris RC |title="Salt-sensitive" essential hypertension in men. Is the sodium ion alone important? |journal=[[N. Engl. J. Med.]] |volume=317 |issue=17 |pages=1043–8 |year=1987 |month=October |pmid=3309653 |doi= |url=}}</ref>  Salt sensitivity itself is associated with increasing age, obesity, African american race, and the [[metabolic syndrome]].<ref>{{cite journal |author=Obarzanek E, Proschan MA, Vollmer WM, ''et al.'' |title=Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial |journal=[[Hypertension]] |volume=42 |issue=4 |pages=459–67 |year=2003 |month=October |pmid=12953018 |doi=10.1161/01.HYP.0000091267.39066.72 |url=http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=12953018}}</ref>



Revision as of 22:12, 3 October 2012

Hypertension Main page

Overview

Causes

Classification

Primary Hypertension
Secondary Hypertension
Hypertensive Emergency
Hypertensive Urgency

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor-In-Chief: Taylor Palmieri

Overview

While the mechanisms underlying secondary hypertension are well understood, the mechanisms underlying primary or essential hypertension are poorly understood. It has been postulated that polygenic influences, increased arterial collagen with aging, salt consumption and sensitivity, hyperinsulinemia as part of the metabolic syndrome and renin may all play a role.

Time Dependence of Pathophysiology

  1. Inability of the kidneys to excrete sodium, resulting in natriuretic factors such as Atrial Natriuretic Factor being secreted to promote salt excretion with the side-effect of raising total peripheral resistance.
  2. An overactive renin / angiotension system leads to vasoconstriction and retention of sodium and water. The increase in blood volume leads to hypertension.
  3. An overactive sympathetic nervous system, leading to increased stress responses.

Genetics

Genetics account for approximately 30% of the expression of the disorder. Hypertension is heritable and polygenic (caused by more than one gene) and a few candidate genes have been identified.[1][2][3]

Salt Sensitivity and Diet

Sodium is the environmental factor that has received the greatest attention. Approximately 60% of the essential hypertension population is responsive to sodium intake. This is due to the fact that increasing amounts of salt in a person's bloodstream causes the body to draw in more water, increasing the pressure on the blood vessel walls. In addition to sodium, choride plays an important role as it causes volume expansion thereby increasing blood pressure. It is notable that sodium, when combined with other anions, does not increase blood pressure. It is only when sodium is combined with chloride does the blood pressure rise. [4] Salt sensitivity itself is associated with increasing age, obesity, African american race, and the metabolic syndrome.[5]

The proposed mechanism for salt-sensitvity is increased salt intake over a long period of time leads to impaired excretion of salt which causes hypertension. There may be several other pathways involved in the pathophysiology of salt-sensitivity leading to hypertension. Salt-sensitive patients are known to have a dysregulated renin-angiotensin pathway and patients show an abnormal vascular response to angiotensin II[6]. Increased sodium re absorption, though not well understood, is mostly related abnormalities across Na-H proximal tubule channels, Na-K-Cl co-transporter across the thick ascending limb, Na-Cl distal tubule co-transporter and epithelial Na channels. Dietary deficiency in potassium is also known to trigger increased sodium sensitivity in patients in particular African-Americans, but the mechanism is not well understood.

Renin

Renin is a hormone secreted by the juxtaglomerular cells of the kidney and linked with aldosterone in a negative feedback loop. The range of renin activity observed in hypertensive subjects tends to be broader than in normotensive individuals. As a consequence, some hypertensive patients have been defined as having low-renin and others as having essential hypertension. Low-renin hypertension is more common in African Americans than Caucasians and may explain why African Americans tend to respond better to diuretic therapy than drugs that interfere with the renin-angiotensin system.

High Renin levels may predispose to hypertension through the following sequence of events: Increased Renin --> Increased Angiotensin II --> Increased Vasoconstriction, Thirst/ADH and Aldosterone --> Increased Sodium Reabsorption in the Kidneys (DCT and CD) --> Increased Blood Pressure.

Insulin resistance

Insulin is a polypeptide hormone secreted by the pancreas. Its main purpose is to regulate the levels of glucose in the body antagonistically with glucagon through negative feedback loops. Insulin also exhibits vasodilatory properties. In normotensive individuals, insulin may stimulate sympathetic activity without elevating mean arterial pressure. However, in more extreme conditions such as that of the metabolic syndrome, the increased sympathetic neural activity may override the vasodilatory effects of insulin. Insulin resistance and/or hyperinsulinemia have been suggested as being responsible for the increased arterial pressure in some patients with hypertension. This feature is now widely recognized as part of syndrome X, or the metabolic syndrome.

Age

As a patient ages, the number of collagen fibers in artery and arteriole walls increases, making blood vessels stiffer, and blood pressure higher for any given stroke volume.

References

  1. Sagnella GA, Swift PA (2006). "The Renal Epithelial Sodium Channel: Genetic Heterogeneity and Implications for the Treatment of High Blood Pressure". Current Pharmaceutical Design. 12 (14): 2221–2234. PMID 16787251. Unknown parameter |month= ignored (help)
  2. Johnson JA, Turner ST (2005). "Hypertension pharmacogenomics: current status and future directions". Current Opinion in Molecular Therapy. 7 (3): 218–225. PMID 15977418. Unknown parameter |month= ignored (help)
  3. Hideo Izawa; Yoshiji Yamada; et al. (2003). "Prediction of Genetic Risk for Hypertension". Hypertension. 41 (5): 1035–1040. PMID 12654703. Unknown parameter |month= ignored (help)
  4. Kurtz TW, Al-Bander HA, Morris RC (1987). ""Salt-sensitive" essential hypertension in men. Is the sodium ion alone important?". N. Engl. J. Med. 317 (17): 1043–8. PMID 3309653. Unknown parameter |month= ignored (help)
  5. Obarzanek E, Proschan MA, Vollmer WM; et al. (2003). "Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial". Hypertension. 42 (4): 459–67. doi:10.1161/01.HYP.0000091267.39066.72. PMID 12953018. Unknown parameter |month= ignored (help)
  6. Chamarthi B, Williams JS, Williams GH (2010). "A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II". J. Hypertens. 28 (5): 1020–6. doi:10.1097/HJH.0b013e3283375974. PMID 20216091. Unknown parameter |month= ignored (help)

Template:WH Template:WS